Eurobio Scientific SA
PAR:ALERS

Watchlist Manager
Eurobio Scientific SA Logo
Eurobio Scientific SA
PAR:ALERS
Watchlist
Price: 25.85 EUR 0.39% Market Closed
Market Cap: 258.6m EUR
Have any thoughts about
Eurobio Scientific SA?
Write Note

EV/EBIT
Enterprise Value to EBIT

20.3
Current
7
Median
4.1
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
20.3
=
Enterprise Value
279.6m EUR
/
EBIT
13.7m EUR
All Countries
Close
EBIT Growth
FR
Eurobio Scientific SA
PAR:ALERS
Average EV/EBIT: 22.2
20.3
121%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 722.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
31.3
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -501.6 N/A
AU
CSL Ltd
ASX:CSL
25.6
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.8 N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
11.6
2-Years Forward
EV/EBIT
10.1
3-Years Forward
EV/EBIT
8.7

See Also

Discover More